Mangalam Organics to Hold Board Meeting on Fundraising Proposal

1 min read     Updated on 12 Sept 2025, 05:58 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
whatsapptwittershare
Overview

Mangalam Organics Limited has announced a board meeting for September 16, 2025, to consider and approve proposals for raising funds from banks or financial institutions. The company has closed the trading window for designated persons from September 12, 2025, until 48 hours after the meeting outcome is made public, in compliance with SEBI regulations.

19225735

*this image is generated using AI for illustrative purposes only.

Mangalam Organics Limited, a leading chemical manufacturing company, has announced a crucial board meeting scheduled for September 16, 2025, to deliberate on potential fundraising activities. This development signals the company's proactive approach to financial planning and strategic growth.

Board Meeting Details

The company has informed the stock exchanges that its Board of Directors will convene on Tuesday, September 16, 2025. The primary agenda for this meeting is to consider and approve proposals for raising funds from banks or financial institutions, subject to necessary approvals.

Regulatory Compliance

In line with regulatory requirements, Mangalam Organics has made this announcement in accordance with Regulations 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This ensures transparency and keeps shareholders and potential investors informed about significant corporate events.

Trading Window Closure

As part of its commitment to prevent insider trading, Mangalam Organics has also announced the closure of the trading window for designated persons and their immediate relatives. The trading window will remain closed from Friday, September 12, 2025, until 48 hours after the outcome of the board meeting is made public. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's Code of Conduct.

Implications for Investors

The upcoming board meeting to discuss fundraising options could have significant implications for Mangalam Organics' future financial strategy. Investors and market analysts will be keenly watching for the outcome of this meeting, as it may provide insights into the company's expansion plans, debt management strategies, or potential new projects that require additional capital.

While the specific details of the fundraising proposal are yet to be disclosed, this move by Mangalam Organics suggests a forward-looking approach to capital management and business growth. Shareholders and potential investors are advised to stay tuned for further updates following the board meeting on September 16, 2025.

As always, investors are encouraged to conduct their own research and consider their financial goals before making any investment decisions.

Historical Stock Returns for Mangalam Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-3.83%-7.75%+38.90%-2.11%-41.52%
Mangalam Organics
View in Depthredirect
like15
dislike

Mangalam Organics Reports Q1 FY2021 Results Amid COVID-19 Challenges

1 min read     Updated on 05 Sept 2025, 07:38 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
whatsapptwittershare
Overview

Mangalam Organics announced unaudited financial results for Q1 FY2021 ending June 30, 2020. The company's operations were significantly impacted by COVID-19 lockdowns, leading to plant and office shutdowns. A phased resumption of operations began in April 2020. The company's assessment concluded no adjustments were needed in the financial statements. The Board of Directors approved the results, which were submitted to the stock exchange with a Limited Review Report from NGST & Associates.

18626944

*this image is generated using AI for illustrative purposes only.

Mangalam Organics , a leading chemical manufacturing company, has announced its unaudited financial results for the quarter ended June 30, 2020, navigating through the challenges posed by the COVID-19 pandemic.

Board Approval and Submission

The company's Board of Directors convened to review and approve the quarterly financial results. The meeting, which concluded at 1:50 p.m., was followed by the submission of the results to the stock exchange, accompanied by a Limited Review Report from the statutory auditors, NGST & Associates.

COVID-19 Impact on Operations

Mangalam Organics reported that its operations were significantly impacted due to the widespread lockdown measures implemented by government authorities to contain the spread of COVID-19. The company experienced plant and office shutdowns across various locations, disrupting normal business activities.

Phased Resumption of Operations

Following government directives, Mangalam Organics initiated a phased resumption of its operations in April 2020. This gradual approach allowed the company to restart its activities while adhering to the necessary safety protocols and guidelines.

Financial Assessment

The company conducted a thorough evaluation of the pandemic's impact on its business operations and liquidity position. Based on this assessment, Mangalam Organics concluded that no adjustments were required in the financial statements for the quarter under review.

Looking Ahead

While the company faces ongoing challenges due to the pandemic, the resumption of operations signals a step towards recovery. Mangalam Organics continues to monitor the situation closely and adapt its strategies to navigate the evolving business landscape.

Investors and stakeholders are advised to consider these factors while assessing the company's performance for the quarter ended June 30, 2020. As the situation remains fluid, Mangalam Organics remains committed to transparent communication and prudent management of its operations in these unprecedented times.

Historical Stock Returns for Mangalam Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-3.83%-7.75%+38.90%-2.11%-41.52%
Mangalam Organics
View in Depthredirect
like18
dislike
More News on Mangalam Organics
Explore Other Articles
530.65
-4.95
(-0.92%)